Top news of the week: 19.07.2022.
Fusion Power Funding, A New EV Battery Plant In Kansas And How Food Waste Costs Taxpayers
This week’s Current Climate, which every Saturday brings you the latest news about the business of sustainability.
Health care’s high rollers: As the pandemic raged, CEOs’ earnings surged
Special Report: Health care’s top executives are cushioned more than ever by the rising fortunes of their stock ownership.
How Venture Capitalists Made Bet on Drugmaker Teneobio Pay Off
Venture-capital backers of Teneobio have parlayed their bet on the biotechnology startup into a series of acquisition deals, illustrating the creativity some investors are using to wring ...
July 13, 2022
ACELYRIN: Appoints Biotechnology Veteran Gil M. Labrucherie as Chief Financial Officer More Arcutis Biotherapeutics: Health Canada Accepts for Review the New Drug Submission for …
Investors See Far Out Profits in Psychedelic Medicine
A former hedge-fund portfolio manager raises millions from scientists, financiers and crypto bros eager to buy into treatments that aren’t even legal yet.
Ultragenyx sells rare disease drug royalties to Canadian pension fund
In exchange for $500 million, the fund, called OMERS, will get a 30% royalty on future sales of Ultragenyx’s drug Crysvita in the U.S. and Canada, where it’s approved to treat two rare ...
CytomX lays off staff, joining growing list of biotechs restructuring
A shaky biotech market has forced another drugmaker to adjust, with CytomX revealing plans to reduce its workforce by 40%.
InnovationRx: Healthtech Funding Halftime Report; Plus, Novavax Vaccine EUA
InnovationRx is your weekly digest of healthcare news. Sign up!